Medica Sur SAB de CV
BMV:MEDICAB

Watchlist Manager
Medica Sur SAB de CV Logo
Medica Sur SAB de CV
BMV:MEDICAB
Watchlist
Price: 58.4 MXN 0.02%
Market Cap: 6.3B MXN

Wall Street
Price Targets

MEDICAB Price Targets Summary
Medica Sur SAB de CV

Wall Street analysts forecast MEDICAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDICAB is 81.6 MXN with a low forecast of 80.8 MXN and a high forecast of 84 MXN.

Lowest
Price Target
80.8 MXN
38% Upside
Average
Price Target
81.6 MXN
40% Upside
Highest
Price Target
84 MXN
44% Upside
Medica Sur SAB de CV Competitors:
Price Targets
UHS
Universal Health Services Inc
24% Upside
TNL
Travel + Leisure Co
6% Upside

Revenue
Forecast

7% / Year
Past Growth
-9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
7% / Year
Past Growth
-9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's revenue is 7%. The projected CAGR for the next 4 years is -9%.

Operating Income
Forecast

4% / Year
Past Growth
-3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
4% / Year
Past Growth
-3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's operating income is 4%. The projected CAGR for the next 4 years is -3%.

Net Income
Forecast

6% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's net income is 6%. The projected CAGR for the next 4 years is -15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDICAB's stock price target?
Price Target
81.6 MXN

According to Wall Street analysts, the average 1-year price target for MEDICAB is 81.6 MXN with a low forecast of 80.8 MXN and a high forecast of 84 MXN.

What is Medica Sur SAB de CV's Revenue forecast?
Projected CAGR
-9%

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's revenue is 7%. The projected CAGR for the next 4 years is -9%.

What is Medica Sur SAB de CV's Operating Income forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's operating income is 4%. The projected CAGR for the next 4 years is -3%.

What is Medica Sur SAB de CV's Net Income forecast?
Projected CAGR
-15%

For the last 13 years the compound annual growth rate for Medica Sur SAB de CV's net income is 6%. The projected CAGR for the next 4 years is -15%.

Back to Top